المؤلفون: Hansen N, Wittig A, Hense J, Kastrup O, Gizewski ER, Van de Nes JAP

المصدر: European Journal of Medical Research, Vol 16, Iss 9, p 415 (2011)

مصطلحات موضوعية: primary diffuse leptomeningeal gliomatosis, temozolomide, radio-chemotherapy, malignant astrocytic cells, survival time, Medicine

Relation: http://www.eurjmedres.com/content/16/9/415; https://doaj.org/toc/2047-783X; https://doaj.org/article/bcdb3c37a071478b8dada0054802fb04

الاتاحة: https://doi.org/10.1186/2047-783X-16-9-415
https://doaj.org/article/bcdb3c37a071478b8dada0054802fb04

المؤلفون: Hansen, N, Wittig, A, Hense, J, Kastrup, O, Gizewski, ER, Van de Nes, JAP

مصطلحات موضوعية: primary diffuse leptomeningeal gliomatosis, temozolomide, radio-chemotherapy, malignant astrocytic cells, survival time

Relation: http://www.eurjmedres.com/content/16/9/415

الاتاحة: http://www.eurjmedres.com/content/16/9/415

المؤلفون: Jap Van de Nes, Niels Hansen, Andrea Wittig, Jörg Hense, Elke R. Gizewski, Oliver Kastrup

المصدر: European Journal of Medical Research, Vol 16, Iss 9, p 415 (2011)
Scopus-Elsevier
European Journal of Medical Research

مصطلحات موضوعية: Male, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Medizin, lcsh:Medicine, Case Report, temozolomide, Meningeal Neoplasms, Humans, Medicine, Antineoplastic Agents, Alkylating, Chemotherapy, Temozolomide, medicine.diagnostic_test, business.industry, Astrocytic Tumor, lcsh:R, Magnetic resonance imaging, Chemoradiotherapy, General Medicine, Middle Aged, Neoplasms, Neuroepithelial, Surgery, Dacarbazine, Survival Rate, Radiation therapy, Irinotecan, Treatment Outcome, Tumor progression, radio-chemotherapy, malignant astrocytic cells, survival time, business, medicine.drug, primary diffuse leptomeningeal gliomatosis

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17ead3741f96319fc19854cb849acde
http://www.eurjmedres.com/content/16/9/415